Amorphous particles enhance oral exposure-a case study of a poorly soluble compound in preclinical, toxicology and early clinical studies

AI kategorie

{
  "language": "lang-en",
  "diagnosis": [
    "ra"
  ],
  "specialty": "rheumatology",
  "study_type": "case-series",
  "evidence_level": "level-3",
  "v6_autopublish": true,
  "clinical_impact": "moderate-impact",
  "practice_recommendation": "monitoring"
}